antibiotics rises exponentially and resistance to new-generation biocides such as triclosan appears 4, 5 , the ability to rely on silver and other less conventional antimicrobial treatments assumes even greater importance and this has led to growing momentum in the design, engineering and applications of nanosilver (NAg) [6] [7] [8] . The appeal of NAg is that its distinct physical, chemical and biological properties deriving from its smaller size (metallic or oxide silver particulates with 1-100 nm dimensions of the particles) afford its greater efficacy as an antimicrobial at lower concentrations, relative to larger micronsized bulk silver.
The reliability of silver as an antimicrobial is, however, under threat. In 2014, the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) 9 , recognised a 'serious knowledge gap' concerning the use of silver nanoparticles and the potential consequent development of resistance mechanisms to them. This Perspective analyses this potential consequence and argues that a real threat exists that resistance to antimicrobial NAg will develop and propagate throughout communities of microorganisms, including those that reside in our bodies. Fuelling this threat is the rapid, widespread, and indiscriminate expansion of NAg application. NAg is now used as a core or co-antimicrobial ingredient in consumer products across numerous application categories, with major usage in health and fitness (personal care, medical care, as dietary supplements), in clothing and other textiles, as well as in home and garden (filters, household appliances and cleaning) and even baby Perspective 3 products 10, 11 . Here, we examine the NAg applications in medical care and dietary supplements for their potential to facilitate prolonged microorganism exposure to bioavailable silver, a key factor in development of resistance in microbial communities. These NAg applications involve direct human contact, facilitating the potential release, absorption, distribution and in turn, accumulation of bioavailable silver in microorganism-inhabited organs and tissues.
The terminology of bioavailable silver from nanosilver
The emphasis in this Perspective will be on 'bioavailable silver' -a term we use in relation to NAg that refers to both Ag particulates and soluble Ag that leach from such particulates; the emphasis here is on bioavailable silver rather than on whether the product on the shelf contains silver or NAg (Box 1 and Figure 1 ). This emphasis is because not all forms of silver exert cytotoxicity against microorganisms.
Silver can be present in a product in one form (metallic silver (Ag(0)) particulates, silver oxide particulates, or cationic silver in various compounds) but can transform through aggregation, agglomeration, dissolution and chemical speciation into alternative forms when the product is in use 12 .
That is, when the silver makes contact with a new environment, such as those occurring when wound dressings are applied and contact is made with the body fluids. Cytotoxic action against microorganisms depends on the bioavailability of the silver, and it is increasingly realised that silver nanoparticles, their bulk silver (>100 nm) counterparts and cationic silver have distinct cytotoxic actions on microorganisms [13] [14] [15] [16] . NAg exhibits superior size-and shape-dependent antimicrobial activity through the action of undissolved Ag particulates, in addition to that from the 'nano-sized' enhanced leaching of soluble silver 13, 14, [17] [18] [19] . Thus, our emphasis is guided by the fact that what is important for the development of resistance to silver is the prolonged exposure of a microorganism to forms of silver that are able to exert biological action on the cell, rather than the form of silver in the product at the point of sale. Attention is drawn particularly to NAg because of its exponential applications, for which antimicrobial action is included for a commercial purpose apart from medical applications. 23 . This was followed by the discovery of a silver-resistant Salmonella typhimurium strain in the 1970s, also isolated from clinical cases of silver nitrate-treated burns (detected as early as day 8, following treatment with 0.5% silver nitrate) 24 . The isolated strain was later characterised as having nine resistance determinants, known as the sil genes 25 . Examples of bacteria adapting to conditions of long exposure to silver are also found outside the clinic, in specific environmental settings 'where toxicity might select for resistance' (a quote from A. Gupta and S. , including the soil of a silver mine and photographic laboratory effluent 6, 26 .
Given the difference in cytotoxic action against microorganisms by different silver chemical species, it may not necessarily follow from the earlier studies that microorganisms exposed to silver nanoparticles will adapt and develop resistance traits to the nanoparticle exposure. It is thus an important question to ask: can microorganisms develop resistance to NAg?
The answer is yes, they can. In 2013, we reported the natural ability of the ubiquitously occurring Bacillus sp. bacteria genus to adapt to NAg in the forms of both high tolerance to NAg and enhanced proliferation 27 . The ability of Bacillus sp. to grow when exposed to NAg levels higher than the microbial toxicity threshold is a result of prolonged prior exposure to NAg. Although the mechanisms by which microorganisms develop resistance effects to NAg are yet to be understood, they may involve defence to oxidative damage invoked by exposure to bioavailable silver 27 . Notably, lethal levels of NAg-stimulated cellular oxidative stress were not required for resistance to develop in Bacillus sp.; the resistance effects Perspective 5 also developed upon prolonged exposure to benign levels of NAg-stimulated cellular oxidative stress. The observed adaption was maintained in the population so that the enhanced proliferation continued even in the absence of NAg exposure. The enhanced proliferation of the Bacillus sp. enabled them to dominate the model microbiota that was the subject of the study (detection of resistant Bacillus sp. as early as day 3 using 3 mg Ag/L) 27 . Bacillus sp. were not the target of the application of NAg -E. coli was, but were rather an environmentally-occurring airborne microorganism introduced at low-levels to contribute to a test microbiota. Similarly, another resistance study to NAg by Khan et 29 .
Published studies describing resistance to various forms of silver raise the cornerstone question for this Supplementary Table S1 , S2 and S3). Our investigation took into account the complexities of silver. Incorporation of non-nanoscale silver in the products, such as silver salts and micron-sized metallic silver, could in fact result in the formation and release of 'secondary' NAg particulates. Ionic silver is capable of undergoing chemical transformation to form nano-sized Ag particulates in biological environments 12, 30, 31 , while metallic silver even as large pieces, has been shown to release NAg particulates under humidity-dependent conditions 32 . In summary, our investigation found that applications of NAg (or silver) in medical care or as dietary supplements could facilitate prolonged microorganism exposure to bioavailable silver in the human body and therefore, the potential for resistance development.
Likely sites for exposure within the human body that we identified include wound bed, oral cavity, gastrointestinal and urinary tracts, all densely-populated microbial habitats with persistent presence of bioavailable silver (Figure 2) , as described in more detail below.
Increasing use of nanosilver products can facilitate prolonged microorganism exposure to bioavailable silver
The commercialisation of silver-containing medical products has seen incorporation of many forms of silver ranging from bound cationic Ag(I), such as silver sulphadiazine and silver sulfate, to the more current and technologically advanced applications of nanocrystalline metallic and oxide silver (Table S1 ).
For wound dressings, these various forms of silver are coated on or impregnated in alginates, polymer- ) and organo Ag-peptide complexes can interact with bacteria and cause cytotoxicity 30, [36] [37] [38] . If present in microbial habitats, the prolonged generation of these bioavailable silver species from the interaction of silver-containing medical products and body fluids suggests the possibility of resistance development.
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To clearly demonstrate this, let us take a closer look at the fates, the series of chemical transformation and the potential of prolonged microorganism exposure to the bioavailable silver derived from wound dressings (see Table S1 for more details). Upon their release, Ag ions interact with the typically abundant presence of chloride and serum proteins in the wound environment 39 . Such interactions will potentially result in the formation of bioavailable Ag species -the soluble Ag(I)-chloride anionic complexes (e.g.
33,36,37 , organo Ag complexes 33, 38 , with a maximum of 1 µg/mL silver expected to remain as free ions 40 . Note that there could also be presence of the biologically inert AgCl precipitate 33, 35, 36 and in the case of NAg dressings, the likely presence of Ag particulates on wound beds will contribute to additional cytotoxic effects 13, 14 (also see Table S3 for forms of silver species in wounds and their bioavailability). Localised exposure of wound microflora to such continual presence of bioavailable silver could facilitate resistance development, in particular with the repeated wound dressing applications on the infection-prone burns and chronic wounds. Apart from contamination by members of the gastrointestinal (gut), the oral cavity and the genitourinary microflora 41 , wounds are also a potential breeding ground for members of the surrounding skin microflora and even the exogenous air-borne microorganisms 41, 42 , of which the latter include Bacillus sp. 43, 44 . With a bacterial burden of at least 10 5 CFU (colony forming units) per gram tissue typically observed in infected wounds 41, 45 , there have indeed been incidences of prevalence and invasive infections of silver-resistant bacteria arising from the wound care applications of silver [46] [47] [48] . This is not contradictory to the in vitro observation of aggressive proliferation of resistant bacteria (exogenous Bacillus sp.) following prolonged exposure to NAg 27 . Further, bacteria containing sil genes with increased persistence to growth inhibition by silver have been detected in members of wound microflora 49 ; although we do not rule out the possibility that such prevalence may be partly attributed to the phenomena of microorganism-to-microorganism transfer of resistance determinants, as later discussed. In 2016, a spontaneous resistance phenomenon was observed in the wound pathogen Proteus mirabilis following one-off exposure to NAg wound dressings, presenting a firmer evidence on the potential implications of NAg wound care applications 50 .
The fate of silver applied to the body through application of wound dressings is not limited to chemical transformations and accumulation in wounds. In cases of prolonged wound dressing application and/or treatment of large wounds, silver has been found to enter the bloodstream through systemic absorption (see Table S1 ) 34 . Here, the absorbed Ag species predominantly exist as organo species due to the high affinity of Ag ions for the thiol (-SH) groups of the amino acids cysteine and methionine present in serum albumins, metallothioneins and macroglobulins [51] [52] [53] as well as in reduced glutathione (GSH), a small antioxidant peptide 30, 54 . Ag ions also have strong affinities for the amino acids histidine, arginine and lysine [55] [56] [57] , which are also thought to be the preferential binding sites of silver in peptides, proteins and biomolecules 12 . Note that it remains unclear at this stage as to the exact routes of silver absorption into the bloodstream and the identities of the absorbable silver species, with several research inquiries leaning toward the systemic uptake of Ag ions 30, 34 and Ag complexes with mobile proteins 34 59 , and as also reported in other studies, persisted before gradually returning to normal levels following discontinuation of the NAg treatment 59, 60 . Silver in urine and therefore in urinary tract, is thought to result from Ag ions and small-sized organo Ag species in the bloodstream passing through the kidney filtration system 61 . Such prolonged presence of bioavailable silver raises the possibility of development of resistant microorganisms (also see Table S3 for forms of silver species in urine and their bioavailability). Similar to wounds, the urinary tract is a microbial habitat.
Apart from the known prevalence of fast-growing microorganisms, quite recent innovations in biomolecular techniques have allowed identification of slow-growing and delicate microorganisms dwelling in the urinary tract, which are otherwise uncultivable with traditional methods 62 . The potential for exposure of these unique microbial communities to bioavailable silver is even more likely with the use of NAg (or Ag)-containing urinary catheters with on-site prolonged release of Ag ions.
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Similarly concerning are the widely marketed NAg dietary supplements. More than simply marketing hype, studies have validated the claimed presence of NAg particulates in many oral supplements as well as in throat and nasal sprays [63] [64] [65] . These NAg (or Ag) applications are likely to facilitate direct accumulation of bioavailable silver in organs and tissues with resident commensal microflora. Without the need for systemic absorption into the bloodstream, deposition of bioavailable silver in the oral cavity and gastrointestinal tract is anticipated following oral intake and ingestion of silver 51, 66 or in the respiratory tract following inhalation of silver 65, 67 . These densely-populated microbial habitats harbour widely diverse microbial communities -including Bacillus sp. as members 1, [68] [69] [70] [71] , that are potentially responsive to the prolonged presence of bioavailable silver to develop resistance effects (see Table S2 and S3 for more details on the fates, chemical transformation and the potential of prolonged microorganism exposure to bioavailable silver at these sites). Not surprisingly, there have been reports of members of gut microflora carrying functional sil genes, with proven resistance to silver 35, 48 . Furthermore, systemic absorption of silver through the buccal (oral cavity) 51 , gastrointestinal 30, 51 and lung alveolar 51 mucosa has been associated with detection of elevated and persistent silver levels in urine [72] [73] [74] and therefore ultimately, the potential for prolonged exposure of urinary microflora to bioavailable silver. The resistance potential aside, the intended accumulation of bioavailable silver in the gut with Ag ingestion could eradicate beneficial resident microflora, leading to colonisation and overgrowth of pathogens in the gut 75 . It has also been well established that changes in the dynamic and balance of gut microflora may lead to an array of undesirable host functions, including inflammation and disrupted energy balance 1, 76 .
Development of resistance to bioavailable silver by microorganisms residing in an individual increases the vulnerability of that individual to infections arising, for example, from medical procedures relying on silver as an antimicrobial in situations whereby antibiotics are less effective (e.g. insertion of catheter).
The resistant microorganisms may spread to other individuals and to the environment and simply increases the pool of resistance determinants. Silver resistance determinants have been increasingly detected in a wide range of clinical and environmental microorganisms isolated from 'ordinary' spots such as hospitals and industrial sites 6 to 'exclusive' locations including the water management systems of the International Space Station 77 . With and without known exposure to silver, these microbes carry sil genes or sil gene-related silver resistance systems, many of which are highly conserved and are located in plasmids as transferrable genetic elements 6 . Such resistance determinants can be passed on to other microorganisms by horizontal gene transfer 6, 78 , which appears, at least in part, to have facilitated the spread of resistance. Given the numerous human body microbial habitats as the resistance-prone sites, the prospect for microorganism-to-microorganism spread of resistance is high with the applications of NAg.
In general, the rate of gene transfer among members of human microflora is 25-fold higher than those in other environments 79 , potentially giving rise to new resistant populations beyond the original sites, even with an already fading presence of bioavailable silver.
Conclusions and Outlook
To conclude, the need for targeted surveillance for the development of microbial resistance in NAg commercialisation has been invoked by: (i) the discovery that microorganisms can adapt to the cytotoxic bioavailable silver and becoming resistant to it, (ii) the widespread use of NAg creating opportunities for prolonged exposure of microbial communities to bioavailable silver, and (iii) the potential for spread of resistance determinants, even to other microorganisms without prior exposure to bioavailable silver.
Whereby NAg applications are considered effective, such as those in wound dressings and catheters, regular monitoring for resistance development in microbial communities is recommended -on contact sites as well as in other human body microbial habitats with persistent presence of systemically absorbed bioavailable silver. The prospect for resistance development is even more intimidating considering the fact that 'real world' applications of NAg mostly deal with the more resilient microbial communities known as biofilms, including those found colonising wounds and surfaces of catheters [80] [81] [82] [83] [84] . The different microbial species in biofilms with their different genotypic and phenotypic traits unite synergistically as a heterogenous and dynamic entity, rendering them less susceptible to antimicrobial agents, including silver 85 . When subjected to ionic or nanocrystalline silver-containing wound treatments, studies have observed less susceptibility of clinically-relevant bacterial biofilms in comparison to their planktonic counterparts 86, 87 . Further, these investigations were focused on single species biofilms and therefore may Perspective 11 not reflect the 'true' toughness of polymicrobial biofilms found in most cases of medical diseases and in nature 85 .
In addition to targeted surveillance for resistance development, the widespread use of NAg needs to be cautiously reassessed for a variety of applications with respect to their risks versus benefits 10, 88 . For example, along with the herein realised potential for resistance development, the NAg dietary supplements are marketed based on unverified claims of "immune system boost" and with no clearly defined antimicrobial targets. Also worth highlighting are the complex and yet seemingly inadequate regulations currently placed upon NAg, creating numerous commercialisation loopholes for NAg use. Control Act (TSCA) with the compositionally identical bulk form silver already on the Chemical Substance Inventory 91 . Such classification has let companies to subject NAg to the same toxicity testing and reporting requirements as bulk silver 91 . This is despite the significant scholarly research reporting differences in their physical and chemical characteristics and consequently, their risks on human and environmental health, as also highlighted in numerous reports by the European Commission's SCENIHR 9,91,92 . The US EPA now acknowledges these differences and assesses NAg separately to bulk silver. As a start, pesticide products that contain NAg must now be registered prior to their release, with the EPA already issuing 'conditional approval' for two products since 2011 10 . Numerous NAg products, however, had been launched prior to this change in EPA rules and these products remain in the market, still promoted based on toxicity evaluation for regular silver 10 .
With this Perspective, we seek to raise awareness of the genuine potential for the current widespread use of NAg to lead to development of microbial resistance and we argue the need for a judicial approach Perspective 12 towards NAg usage. Without effective regulated use of NAg and without efforts to monitor for potential (or realised) resistance development, the capacity of NAg as an alternative antimicrobial weapon in the era of increasing antibiotic resistance will be diminished. The hazard presented by indiscriminate use of NAg is further underscored by intriguing new evidence of shifts in antibiotic resistance gene profiles in microbial communities when subjected to presence of NAg 93 . Beyond a weakened antimicrobial arsenal, unnecessary applications of NAg will unnecessarily change the balance and dynamics of endogenous microflora, not only those that dwell in the human body but also in the environment. The ripple effect of such disruptions has myriad impacts on human and environmental health and should not be ignored.
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Figure 2.
Resistance-prone sites: potential prolonged exposure of resident commensal microflora to the presence of bioavailable silver in various human body locations. Presence of bioavailable silver is through release, absorption, distribution and accumulation of silver species from nanosilver products.
